Skip to main content
. Author manuscript; available in PMC: 2021 Mar 1.
Published in final edited form as: Ann Surg Oncol. 2019 Dec 2;27(3):898–906. doi: 10.1245/s10434-019-08094-0

FIG. 1.

FIG. 1

Overall survival estimate for patients with a post-neoadjuvant treatment systemic immune-inflammation index (SII) greater than 900 (median overall survival, 27.50 vs 20.03 months; p = 0.050)